🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
491 results for “Novo”
MedicineActive substanceLicence holderStatus
Candesartan Hydrochlorothiazide Krka 8mg/12.5mg tablets
PA1347/011/001
Candesartan cilexetil, Hydrochlorothiazide KRKA, d.d., Novo mesto Not marketed
Candesartan Krka 16 mg tablets
PA1347/026/003
Candesartan cilexetil KRKA, d.d., Novo mesto Marketed
Candesartan Krka 32 mg Tablets
PA1347/026/004
Candesartan cilexetil KRKA, d.d., Novo mesto Not marketed
Candesartan Krka 4 mg tablets
PA1347/026/001
Candesartan cilexetil KRKA, d.d., Novo mesto Marketed
Candesartan Krka 8 mg tablets
PA1347/026/002
Candesartan cilexetil KRKA, d.d., Novo mesto Marketed
Carvedilol Krka 12.5 mg Tablets
PA1347/037/003
Carvedilol KRKA, d.d., Novo mesto Marketed
Carvedilol Krka 25 mg Tablets
PA1347/037/004
Carvedilol KRKA, d.d., Novo mesto Marketed
Carvedilol Krka 3.125 mg Tablets
PA1347/037/001
Carvedilol KRKA, d.d., Novo mesto Marketed
Carvedilol Krka 6.25 mg tablets
PA1347/037/002
Carvedilol KRKA, d.d., Novo mesto Marketed
Celecoxib Krka 100 mg capsules, hard
PA1347/033/001
Celecoxib KRKA, d.d., Novo mesto Marketed
Celecoxib Krka 200 mg capsules, hard
PA1347/033/002
Celecoxib KRKA, d.d., Novo mesto Marketed
Ciprofloxacin Krka 250 mg film-coated tablets
PA1347/035/001
Ciprofloxacin KRKA, d.d., Novo mesto Marketed
Ciprofloxacin Krka 500 mg film-coated tablets
PA1347/035/002
Ciprofloxacin KRKA, d.d., Novo mesto Marketed
Ciprofloxacin Krka 750 mg film-coated tablets
PA1347/035/003
Ciprofloxacin KRKA, d.d., Novo mesto Marketed
Clarithromycin Krka 250 mg film-coated tablets
PA1347/068/001
Clarithromycin KRKA, d.d., Novo mesto Not marketed
Clarithromycin Krka 500 mg film-coated tablets
PA1347/068/002
Clarithromycin KRKA, d.d., Novo mesto Not marketed
Clopidogrel Krka 75 mg film-coated tablets
EU/1/09/556/1-9
Clopidogrel hydrochloride KRKA, d.d., Novo mesto
Clopidogrel Krka d.d. 75 mg film-coated tablet
EU/1/09/562/001-9
Clopidogrel hydrochloride KRKA, d.d., Novo mesto
Dabigatran Etexilate Krka 110 mg hard capsules
PA1347/110/002
Dabigatran etexilate mesilate KRKA, d.d., Novo mesto Marketed
Dabigatran Etexilate Krka 150 mg hard capsules
PA1347/110/003
Dabigatran etexilate mesilate KRKA, d.d., Novo mesto Marketed
Dabigatran Etexilate Krka 75 mg hard capsules
PA1347/110/001
Dabigatran etexilate mesilate KRKA, d.d., Novo mesto Not marketed
Dalnecombi 7 mg/5 mg/2.5 mg tablets
PA1347/117/001
Perindopril arginine, Amlodipine besilate, Indapamide KRKA, d.d., Novo mesto Not marketed
Dapagliflozin Krka 10 mg film-coated tablets
PA1347/111/002
Dapagliflozin propanediol monohydrate KRKA, d.d., Novo mesto Not marketed
Dapagliflozin Krka 5 mg film-coated tablets
PA1347/111/001
Dapagliflozin propanediol monohydrate KRKA, d.d., Novo mesto Not marketed
Dapagliflozin/Metformin Krka 5 mg/1000 mg film-coated tablets
PA1347/118/002
Dapagliflozin propanediol monohydrate, Metformin Hydrochloride KRKA, d.d., Novo mesto Not marketed
Dapagliflozin/Metformin Krka 5 mg/850 mg film-coated tablets
PA1347/118/001
Dapagliflozin propanediol monohydrate, Metformin Hydrochloride KRKA, d.d., Novo mesto Not marketed
Darunavir Krka 400 mg Film-coated tablet
EU/1/17/1249/001-004
Darunavir KRKA, d.d., Novo mesto
Darunavir Krka 600 mg Film-coated tablet
EU/1/17/1249/005-008
Darunavir KRKA, d.d., Novo mesto
Darunavir Krka 800 mg Film-coated tablet
EU/1/17/1249/009-010
Darunavir KRKA, d.d., Novo mesto
Darunavir Krka d.d.
EU/1/17/1248/001-004
Darunavir KRKA, d.d., Novo mesto
Darunavir Krka d.d.
EU/1/17/1248/005-008
Darunavir KRKA, d.d., Novo mesto
Darunavir Krka d.d.
EU/1/17/1248/009-010
Darunavir KRKA, d.d., Novo mesto
Dasatinib Krka 100 mg film-coated tablets
PA1347/093/005
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 140 mg film-coated tablets
PA1347/093/006
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 20 mg film-coated tablets
PA1347/093/001
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 50 mg film-coated tablets
PA1347/093/002
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 70 mg film-coated tablets
PA1347/093/003
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasatinib Krka 80 mg film-coated tablets
PA1347/093/004
Dasatinib KRKA, d.d., Novo mesto Not marketed
Dasselta 5 mg film-coated tablets
EU/1/11/739/001-008
Desloratadine KRKA, d.d., Novo mesto
Dexamethasone Phosphate Krka 4 mg/ml solution for injection/infusion
PA1347/091/001
Dexamethasone sodium phosphate KRKA, d.d., Novo mesto Marketed
Diacronal MR 30 mg modified-release tablets
PA1347/024/002
Gliclazide KRKA, d.d., Novo mesto Marketed
Diacronal MR 60 mg modified-release tablets
PA1347/024/001
Gliclazide KRKA, d.d., Novo mesto Marketed
Donepezil Krka 10 mg film-coated tablets
PA1347/014/004
Donepezil hydrochloride KRKA, d.d., Novo mesto Marketed
Donepezil Krka 5 mg film-coated tablets
PA1347/014/003
Donepezil hydrochloride KRKA, d.d., Novo mesto Marketed
Duloxetine Krka 30 mg hard gastro-resistant capsules
PA1347/051/002
Duloxetine hydrochloride KRKA, d.d., Novo mesto Marketed
Duloxetine Krka 60 mg hard gastro-resistant capsules
PA1347/051/004
Duloxetine hydrochloride KRKA, d.d., Novo mesto Marketed
Dutasteride Krka 0.5 mg capsules, soft
PA1347/069/001
Dutasteride KRKA, d.d., Novo mesto Marketed
Ecansya 300 mg film-coated tablets
EU/1/12/763/007-012
Capecitabine KRKA, d.d., Novo mesto
Ecansya 500 mg film-coated tablets
EU/1/12/763/001-006
Capecitabine KRKA, d.d., Novo mesto
Ecansya 500 mg film-coated tablets
EU/1/12/763/013-018
Capecitabine KRKA, d.d., Novo mesto
1 2 3 4 5

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.